Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - AccuredReceivables - NetReceivables - OtherRevenue - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Perspective Therapeutics (CATX) Leases (2019 - 2026)

Perspective Therapeutics' Leases history spans 10 years, with the latest figure at $2.4 million for Q1 2026.

  • On a quarterly basis, Leases rose 22.57% to $2.4 million in Q1 2026 year-over-year; TTM through Mar 2026 was $2.4 million, a 22.57% increase, with the full-year FY2025 number at $1.5 million, down 32.28% from a year prior.
  • Leases hit $2.4 million in Q1 2026 for Perspective Therapeutics, up from $1.5 million in the prior quarter.
  • Over the last five years, Leases for CATX hit a ceiling of $2.4 million in Q1 2026 and a floor of $309000.0 in Q1 2023.
  • Historically, Leases has averaged $1.4 million across 5 years, with a median of $1.5 million in 2023.
  • The widest YoY moves for Leases: up 243.6% in 2023, down 46.45% in 2023.
  • Tracing CATX's Leases over 5 years: stood at $445000.0 in 2022, then soared by 67.87% to $747000.0 in 2023, then surged by 196.52% to $2.2 million in 2024, then plummeted by 32.28% to $1.5 million in 2025, then skyrocketed by 62.93% to $2.4 million in 2026.
  • Business Quant data shows Leases for CATX at $2.4 million in Q1 2026, $1.5 million in Q4 2025, and $1.5 million in Q3 2025.